reversal of deferred tax assets. Financial Ratios Q2 2020 Q2 2019 Gross profit margin 18.9% 20.7% Net profit margin 8.5% 14.3% Debt to Equity ratio 0.18 0.10 Earnings per share 0.26 0.57 ROA 6.1% 12.2% ROE
addition, the company market share increased from 4.34% to 6.69% compare to the same period last year. 2. The Consolidated and the separated statements recorded Baht 42.89 million as fees and service income
) (14.6) Total Expenses 2,260.9 67.8 2,415.9 73.4 155.0 6.9 Profit from operating activities 1,075.6 32.2 876.5 26.6 (199.1) (18.5) Share of gain (loss) from investments in joint ventures (69.1) (2.1) 61.4
. Share of profit (loss) from investment in associated company For Quarter 2 of the year 2020, share of profit from investment in associated company was 9.19 million baht compare to 4.92 million bath last
period of the previous year resulting from the increasing of market share. 2. Total expense for the 2nd Quarter ended 30 June 2020 was decreased 1.99% from Baht 270.97 million to Baht 265.57 million
56.89 million baht in 2018 4. Ramkhamhaeng Hospital Public Company Limited received share of profit from investment in associated company in the amount of 455.41 and 546.75 million baht in 2018 and 2019
Public Company Limited’s subsidiary company (“The Company”), Joint Venture Ureka UU co., ltd. (“UU”), in which the company hold 90% of the share. The company plans to increase the shareholding to 99%. On
, the company market share increased from 3.36% to 6.87% compare to the same period last year. 2. The Consolidated and the separated statements recorded Baht 16.99 million as fees and service income
) SHARE OF LOSS OF INVESTMENT IN JOINT VENTURES ON EQUITY METHOD (0.00) (0.57) PROFIT BEFORE TAX 62.83 4.52 INCOME TAX INCOME 0.48 0.56 PROFIT FOR THE PERIODS FROM CONTINUTING OPERATIONS 63.31 5.08 PROFIT
426.73 million compared to the same period of the previous year resulting from the increasing of market share and the expansion of business area. 2. Total expense for the 1st Quarter ended 31 March 2020